Free Trial
NASDAQ:ONCR

Oncorus (ONCR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.13
$0.20
50-Day Range
$0.01
$0.13
52-Week Range
$0.01
$0.47
Volume
135,900 shs
Average Volume
1.33 million shs
Market Capitalization
$3.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ONCR stock logo

About Oncorus Stock (NASDAQ:ONCR)

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts.

ONCR Stock News Headlines

Comera Life Sciences Holdings Inc
Oncorus Inc Ordinary Shares
ONCR Historical Data
Oncorus Announces Workforce Reduction Plan
Recap: Oncorus Q1 Earnings
Oncorus to Participate in Upcoming Investor Conferences
Recap: Oncorus Q3 Earnings
Oncorus, Inc. (NASDAQ: ONCR)
See More Headlines
Receive ONCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncorus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/22/2023
Today
6/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ONCR
Fax
N/A
Employees
64
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.33 per share

Miscellaneous

Free Float
21,633,000
Market Cap
$3.29 million
Optionable
Optionable
Beta
3.60
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Craig R. Jalbert CIRA (Age 61)
    CEO, President, CFO, Treasurer, Secretary & Director
  • Chris German
    Controller

ONCR Stock Analysis - Frequently Asked Questions

How were Oncorus' earnings last quarter?

Oncorus, Inc. (NASDAQ:ONCR) issued its quarterly earnings results on Monday, May, 22nd. The company reported ($1.18) EPS for the quarter, missing the consensus estimate of ($0.70) by $0.48.

What other stocks do shareholders of Oncorus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oncorus investors own include Cronos Group (CRON), Deere & Company (DE), GrowGeneration (GRWG), Immunomedics (IMMU), Teck Resources (TECK), Abbott Laboratories (ABT), Ability (ABIL), AbbVie (ABBV), Atlas Air Worldwide (AAWW).

When did Oncorus IPO?

Oncorus (ONCR) raised $87 million in an IPO on Friday, October 2nd 2020. The company issued 5,800,000 shares at $14.00-$16.00 per share. Jefferies, Evercore ISI and Piper Sandler acted as the underwriters for the IPO.

This page (NASDAQ:ONCR) was last updated on 6/16/2024 by MarketBeat.com Staff

From Our Partners